Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.810
+0.150 (5.64%)
Sep 2, 2026, 5:29 PM CET
Elicera Therapeutics AB Employees
Elicera Therapeutics AB had 3 employees as of March 31, 2026. The number of employees increased by 1 or 50.00% since the number was last reported on December 31, 2025.
Employees
3
Change
1
Growth
50.00%
Revenue / Employee
2.60M SEK
Profits / Employee
-5.99M SEK
Market Cap
177.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 3 | 1 | 50.00% |
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | 0 | - |
| Dec 31, 2023 | 2 | 0 | - |
| Dec 31, 2022 | 2 | 1 | 100.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Diamyd Medical AB | 44 |
| Xbrane Biopharma AB | 29 |
| Biovica International AB | 25 |
| NextCell Pharma AB | 24 |
| Xintela AB | 11 |
| Alzinova AB | 7 |
| Isofol Medical AB | 7 |
| Abera Bioscience AB | 6 |
Elicera Therapeutics AB News
- 5 days ago - Elicera Therapeutics AB Quarterly report: Q2 2026 - Filings
- 4 months ago - Elicera Therapeutics AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Elicera Therapeutics AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Elicera Therapeutics AB Annual report: Q4 2025 - Filings
- 9 months ago - Elicera Therapeutics AB Quarterly report: Q3 2025 - Filings